Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Combined use of liquid chromatography-nuclear magnetic resonance spectroscopy and liquid chromatography-mass spectrometry for the characterization of an acarbose degradation product (CROSBI ID 114042)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Novak, Predrag ; Tepeš, Predrag ; Cindrić, Mario ; Ilijaš, Marina ; Dragojević, Snježana ; Mihaljević, Krešo Combined use of liquid chromatography-nuclear magnetic resonance spectroscopy and liquid chromatography-mass spectrometry for the characterization of an acarbose degradation product // Journal of Chromatography A, 1033 (2004), 2; 299-303. doi: 10.1016/j.chroma.2004.01.055

Podaci o odgovornosti

Novak, Predrag ; Tepeš, Predrag ; Cindrić, Mario ; Ilijaš, Marina ; Dragojević, Snježana ; Mihaljević, Krešo

engleski

Combined use of liquid chromatography-nuclear magnetic resonance spectroscopy and liquid chromatography-mass spectrometry for the characterization of an acarbose degradation product

Directly coupled LC-MS and LC-NMR were applied to identify and structurally characterize an acarbose degradation product A in acidic media. A comparative analysis of the stop-flow LC-NMR (1H and TOCSY) and LC-MS data provided evidence that A is structurally related to acarbose, differing from the parent compound in a number of subunits present in the molecule. Spectral analysis revealed that A was the alpha-glucosidase inhibitor amylostatin XG. Complementary information obtained from the two methods led to the structural elucidation of A which was later corroborated by high-resolution NMR spectroscopy of the isolated molecule.

nuclear magnetic resonance spectroscopy; acarbose

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

1033 (2)

2004.

299-303

objavljeno

0021-9673

10.1016/j.chroma.2004.01.055

Povezanost rada

Kemija, Farmacija

Poveznice
Indeksiranost